The Development and Implementation of a Cardiac Home Hospice Program: Results of a RE-AIM Analysis.
RE-AIM
analysis
cardiac hospice program
comfort care
end of life care
heart failure
home hospice care
Journal
The American journal of hospice & palliative care
ISSN: 1938-2715
Titre abrégé: Am J Hosp Palliat Care
Pays: United States
ID NLM: 9008229
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
pubmed:
19
5
2020
medline:
29
7
2021
entrez:
19
5
2020
Statut:
ppublish
Résumé
Use of hospice has grown among patients with heart failure; however, gaps remain in the ability of agencies to tailor services to meet their needs. This study describes the implementation of a cardiac home hospice program and insights for dissemination to other hospice programs. We conducted a multimethod analysis structured around the Reach Effectiveness Adoption Implementation and Maintenance (RE-AIM) framework. We used electronic medical records for our quantitative data source and interviews with hospice clinicians from a not-for-profit hospice agency (N = 32) for our qualitative data source. Reach-A total of 1273 participants were enrolled in the cardiac home hospice program, of which 57% were female and 42% were black or Hispanic with a mean age was 86 years. Effectiveness-The cardiac home hospice program increased hospice enrollment among patients with heart failure from 7.9% to 9.5% over 1 year (2016-2017). Adoption-Institutional factors that supported the program included the acute need to support medically complex patients at the end of life and an engaged clinical champion. Implementation-Program implementation was supported by interdisciplinary teams who engaged in care coordination. Maintenance-The program has been maintained for over 3 years. The cardiac home hospice program strengthened hospice clinicians' ability to confidently provide care for patients with heart failure, expanded awareness of their symptoms among clinicians, and was associated with increased enrollment of patients with heart failure over the study period. This RE-AIM evaluation provides lessons learned and strategies for future adoption, implementation, and maintenance of a cardiac home hospice program.
Sections du résumé
BACKGROUND
BACKGROUND
Use of hospice has grown among patients with heart failure; however, gaps remain in the ability of agencies to tailor services to meet their needs.
AIM
OBJECTIVE
This study describes the implementation of a cardiac home hospice program and insights for dissemination to other hospice programs.
DESIGN
METHODS
We conducted a multimethod analysis structured around the Reach Effectiveness Adoption Implementation and Maintenance (RE-AIM) framework.
SETTINGS/PARTICIPANTS
METHODS
We used electronic medical records for our quantitative data source and interviews with hospice clinicians from a not-for-profit hospice agency (N = 32) for our qualitative data source.
RESULTS
RESULTS
Reach-A total of 1273 participants were enrolled in the cardiac home hospice program, of which 57% were female and 42% were black or Hispanic with a mean age was 86 years. Effectiveness-The cardiac home hospice program increased hospice enrollment among patients with heart failure from 7.9% to 9.5% over 1 year (2016-2017). Adoption-Institutional factors that supported the program included the acute need to support medically complex patients at the end of life and an engaged clinical champion. Implementation-Program implementation was supported by interdisciplinary teams who engaged in care coordination. Maintenance-The program has been maintained for over 3 years.
CONCLUSION
CONCLUSIONS
The cardiac home hospice program strengthened hospice clinicians' ability to confidently provide care for patients with heart failure, expanded awareness of their symptoms among clinicians, and was associated with increased enrollment of patients with heart failure over the study period. This RE-AIM evaluation provides lessons learned and strategies for future adoption, implementation, and maintenance of a cardiac home hospice program.
Identifiants
pubmed: 32421373
doi: 10.1177/1049909120925432
pmc: PMC7415712
mid: NIHMS1602134
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
925-935Subventions
Organisme : NINR NIH HHS
ID : R00 NR016275
Pays : United States
Références
J Pain Symptom Manage. 2013 Mar;45(3):552-60
pubmed: 22940560
JACC Heart Fail. 2018 Sep;6(9):780-789
pubmed: 30098966
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Appl Clin Inform. 2018 Jul;9(3):693-703
pubmed: 30184559
ESC Heart Fail. 2019 Apr;6(2):371-378
pubmed: 30835970
Card Fail Rev. 2019 May 24;5(2):93-98
pubmed: 31179019
J Palliat Med. 2010 Aug;13(8):973-9
pubmed: 20642361
J Palliat Med. 2018 Nov;21(11):1651-1661
pubmed: 30129809
J Am Geriatr Soc. 2019 Apr;67(4):804-810
pubmed: 30693950
Prog Cardiovasc Dis. 2011 Sep-Oct;54(2):168-78
pubmed: 21875515
Curr Opin Cardiol. 2018 Mar;33(2):202-207
pubmed: 29135524
Circ Heart Fail. 2015 Jul;8(4):733-40
pubmed: 26019151
Milbank Q. 2011 Sep;89(3):343-80
pubmed: 21933272
Health Aff (Millwood). 2013 Mar;32(3):552-61
pubmed: 23459735
Soc Sci Med. 2007 Oct;65(7):1466-78
pubmed: 17600605
JACC Heart Fail. 2019 Jul;7(7):550-557
pubmed: 31078473
Am Heart J. 2009 Jul;158(1):118-25
pubmed: 19540401
Eur Heart J. 2002 Dec;23(23):1867-76
pubmed: 12445536
Arch Intern Med. 2007 Oct 8;167(18):1990-7
pubmed: 17923600
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Heart Fail Rev. 2017 Jan;22(1):25-39
pubmed: 27592330
Circ Heart Fail. 2017 Mar;10(3):
pubmed: 28292824
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239
pubmed: 23747642
PLoS One. 2017 Jul 28;12(7):e0182148
pubmed: 28753675
Herz. 2019 Aug;44(5):440-444
pubmed: 29468259
JAMA. 2014 Nov 12;312(18):1888-96
pubmed: 25387186